Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models.

Source:http://linkedlifedata.com/resource/pubmed/id/17961733

Regul. Pept. 2008 Feb 7 146 1-3 46-57

Download in:

View as

Triples

General Info

PMID
17961733